Lori Deemer
Family Medicine · Greenfield, INNPI 1770585317
Payments from drug & device makers
Across 118 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$370
- AbbVie$285
- Novo Nordisk$218
- Novartis$118
- Medtronic$101
- Astellas Pharma US Inc$100
- plus $635 from 21 others
What the payments were for
- Food & beverage$1,71894%
- Education$1086%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 30 | $370 |
| AbbVie(2 entities) | 17 | $285 |
| Novo Nordisk | 22 | $218 |
| Novartis | 8 | $118 |
| Medtronic | 1 | $101 |
| Astellas Pharma US Inc | 1 | $100 |
| GSK | 5 | $79 |
| Boehringer Ingelheim | 5 | $72 |
| Pfizer | 5 | $71 |
| Arbor Pharmaceuticals, Inc. | 1 | $63 |
| AstraZeneca | 3 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Abbott | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Neos Therapeutics, LP | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $20 |
| Exact Sciences | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Amgen | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Circassia Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$101
How this compares
$1,826 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $15,148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $370 | $15,14814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Greenfield
- Talessa PowellGreenfield$1.4M
- Thomas O'ConnorGreenfield$228K
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.